Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

464 ARTÍCULOS , VIENDO DEL 346 AL 360

Severe hyponatremia and seizures secondary to psychogenic polydipsia in a case of frontotemporal dementia

Appleby BS, Tanase D.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):E19-20. doi: 10.1176/appi.neuropsych.13100237.

Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease

Gainotti G, Quaranta D, Vita MG, Marra C.

J Alzheimers Dis. 2014;38(3):481-95. doi: 10.3233/JAD-130881.

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers

Shen L, Thompson PM, Potkin SG, Bertram L, Farrer LA, Foroud TM, Green RC, Hu X, Huentelman MJ, Kim S, Kauwe JS, Li Q, Liu E, Macciardi F, Moore JH, Munsie L, Nho K, Ramanan VK, Risacher SL, Stone DJ, Swaminathan S, Toga AW, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2014 Jun;8(2):183-207. doi: 10.1007/s11682-013-9262-z.

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers

Reitz C, Mayeux R.

Biochem Pharmacol. 2014 Apr 15;88(4):640-51. doi: 10.1016/j.bcp.2013.12.024. Epub 2014 Jan 4.

Amyloid beta 1-42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer's disease

Shea YF, Chu LW, Mok MY, Lam MF.

J Nephrol. 2014 Apr;27(2):217-20. doi: 10.1007/s40620-014-0043-6. Epub 2014 Jan 29.

Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease

Wang C, Yu JT, Wang HF, Jiang T, Tan CC, Meng XF, Soares HD, Tan L.

PLoS One. 2014 Feb 18;9(2):e89041. doi: 10.1371/journal.pone.0089041. eCollection 2014.

Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment

Amlien IK, Fjell AM.

Neuroscience. 2014 Sep 12;276:206-15. doi: 10.1016/j.neuroscience.2014.02.017. Epub 2014 Feb 27.

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M.

J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191.

Plasma phospholipids identify antecedent memory impairment in older adults

Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ.

Nat Med. 2014 Apr;20(4):415-8. doi: 10.1038/nm.3466. Epub 2014 Mar 9.

Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Sauvée M, DidierLaurent G, Latarche C, Escanyé MC, Olivier JL, Malaplate-Armand C.

J Alzheimers Dis. 2014;41(2):377-86. doi: 10.3233/JAD-131838.

[Biomarkers in Alzheimer's disease]

García-Ribas G, López-Sendón Moreno JL, García-Caldentey J.

Rev Neurol. 2014 Apr 1;58(7):308-17.

Early detection of Alzheimer's disease using PiB and FDG PET

Cohen AD, Klunk WE.

Neurobiol Dis. 2014 Dec;72 Pt A:117-22. doi: 10.1016/j.nbd.2014.05.001. Epub 2014 May 10.

The involvement of lipids in Alzheimer's disease

Lim WL, Martins IJ, Martins RN.

J Genet Genomics. 2014 May 20;41(5):261-74. doi: 10.1016/j.jgg.2014.04.003. Epub 2014 May 2.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.

The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations

Mormino EC.

Neuropsychol Rev. 2014 Sep;24(3):300-12. doi: 10.1007/s11065-014-9267-4. Epub 2014 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias